Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder

被引:4
|
作者
Sakaguchi, Ryuki [1 ]
Fujikawa, Keita [1 ]
Okamoto, Momoko [1 ]
Matsuo, Emi [2 ]
Matsumoto, Kohei [3 ]
Uchida, Tomohisa [1 ]
Shin-ya, Kawashiri [4 ]
Nakashima, Masahiro [5 ]
Mizokami, Akinari [1 ]
Kawakami, Atsushi [4 ]
机构
[1] Isahaya Gen Hosp, Dept Rheumatol, Japan Community Healthcare Org, Isahaya, Japan
[2] Isahaya Gen Hosp, Dept Hematol, Japan Community Healthcare Org, Isahaya, Japan
[3] Isahaya Gen Hosp, Dept Otolaryngol, Japan Community Healthcare Org, Isahaya, Japan
[4] Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Nagasaki, Japan
[5] Nagasaki Univ, Atom Bomb Dis Inst, Dept Tumor & Diagnost Pathol, Nagasaki, Japan
关键词
nasal septum perforation; methotrexate-associated lymphoproliferative disorder; peripheral T-cell lymphoma; rheumatoid arthritis; EPSTEIN-BARR-VIRUS; VASCULITIS; LYMPHOMA; PATIENT;
D O I
10.2169/internalmedicine.2995-19
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 44-year-old female with rheumatoid arthritis treated with methotrexate (MTX) and tocilizumab (TCZ) was admitted to our hospital with nasal pain. Nasal fiberscopy revealed septum perforation, while a membrane biopsy indicated granuloma and fibrinoid necrosis of the small artery. The patient was treated with prednisolone 30 mg/day after discontinuation of MTX and TCZ. Inguinal lymph node biopsy revealed diffuse infiltrations of atypical T-cells and Epstein-Barr virus-positive B cells. The patient was diagnosed with peripheral T-cell lymphoma due to MTX-associated lymphoproliferative disorder (MTX-LPD). We herein describe the case of a patient with nasal septum perforation due to MTX-LPD mimicking granulomatosis with polyangiitis.
引用
收藏
页码:3167 / 3171
页数:5
相关论文
共 50 条
  • [41] Gastric Perforation due to Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder during the Treatment of Rheumatoid Arthritis
    Toyama, Shiho
    Takatani, Ayuko
    Koga, Tomohiro
    Eguchi, Mizuna
    Okamoto, Momoko
    Tsuji, Sosuke
    Endo, Yushiro
    Shimizu, Toshimasa
    Sumiyoshi, Remi
    Igawa, Takashi
    Kawashiri, Shin-Ya
    Iwamoto, Naoki
    Ichinose, Kunihiro
    Tamai, Mami
    Nakamura, Hideki
    Origuchi, Tomoki
    Furuyama, Masako
    Tabuchi, Maiko
    Kobayashi, Shinichiro
    Kanetaka, Kengo
    Hashisako, Mikiko
    Abe, Kuniko
    Niino, Daisuke
    Sato, Shinya
    Miyazaki, Yasushi
    Kawakami, Atsushi
    INTERNAL MEDICINE, 2019, 58 (22) : 3331 - 3336
  • [42] A case of methotrexate-associated lymphoproliferative disorder accompanied by osteonecrosis of the maxilla
    Saito, Shota
    Murakami, Takuya
    Koshinuma, Shinya
    Higo, Tomoki
    Tsutsumi, Yasuhiko
    Yamamoto, Gaku
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY MEDICINE AND PATHOLOGY, 2015, 27 (06) : 834 - 838
  • [43] Methotrexate-associated Lymphoproliferative Disorder: A Rare Differential Diagnosis of Wheezes
    Ujino, Mariko
    Miyoshi, Shoki
    Sugimoto, Naoya
    Arai, Hidenori
    Ota, Yasunori
    Sasajima, Yuko
    Kawamura, Masafumi
    Nagase, Hiroyuki
    Yamaguchi, Masao
    Ohta, Ken
    INTERNAL MEDICINE, 2019, 58 (12) : 1759 - 1764
  • [44] FDG-PET/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis
    Tomohiro Kameda
    Shusaku Nakashima
    Katsuya Mitamura
    Yuka Yamamoto
    Takashi Norikane
    Hiromi Shimada
    Risa Wakiya
    Mikiya Kato
    Taichi Miyagi
    Koichi Sugihara
    Rina Mino
    Mao Mizusaki
    Norimitsu Kadowaki
    Hiroaki Dobashi
    Scientific Reports, 12
  • [45] Methotrexate-associated lymphoproliferative disorder presenting as giant ulcers on the leg
    Oka, T.
    Miyagaki, T.
    Nakamura, R.
    Funamizu, K.
    Sugaya, M.
    Ebisawa, K.
    Koya, J.
    Kurokawa, M.
    Sato, S.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2018, 43 (08) : 930 - 933
  • [46] FDG-PET/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis
    Kameda, Tomohiro
    Nakashima, Shusaku
    Mitamura, Katsuya
    Yamamoto, Yuka
    Norikane, Takashi
    Shimada, Hiromi
    Wakiya, Risa
    Kato, Mikiya
    Miyagi, Taichi
    Sugihara, Koichi
    Mino, Rina
    Mizusaki, Mao
    Kadowaki, Norimitsu
    Dobashi, Hiroaki
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [47] Methotrexate-associated lymphoproliferative disorder masquerading as interstitial lung disease
    Jois, R. N.
    Gaffney, K.
    Cane, P.
    Nicholson, A. G.
    Wotherspoon, A. C.
    HISTOPATHOLOGY, 2007, 51 (05) : 709 - 712
  • [48] Methotrexate-associated lymphoproliferative disorder with hypopituitarism and central diabetes insipidus
    Aoshima, Misaki
    Nagayama, Koji
    Takeshita, Kei
    Ajima, Hiroshi
    Orikasa, Sakurako
    Iwazaki, Ayana
    Takatori, Hiroaki
    Oki, Yutaka
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2019,
  • [49] Unusual manifestation of methotrexate-associated lymphoproliferative disorder as a palatal mass
    Watanabe, Takuma
    Teratani, Yukina
    BMJ CASE REPORTS, 2022, 15 (09)
  • [50] A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder
    Ruby Matsumoto
    Kazushi Numata
    Nobutaka Doba
    Koji Hara
    Makoto Chuma
    Hiroyuki Fukuda
    Akito Nozaki
    Katsuaki Tanaka
    Yoshimi Ishii
    Shin Maeda
    Journal of Medical Ultrasonics, 2016, 43 : 545 - 551